Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

5-(2,6-Difluoro-phenoxy)-3(R,S)-{2(S)-[2(S)-(3-methoxycarbonyl-2(S)-{3-methyl-2(S)-[(quinoline-2-carbonyl)-amino]-butyrylamino}-propionylamino)-3-methyl-butyrylamino]-propionylamino}-4-oxo-pentanoic acid methyl ester

EU orphan designation number: EU/3/06/403   
Active ingredient: 5-(2,6-Difluoro-phenoxy)-3(R,S)-{2(S)-[2(S)-(3-methoxycarbonyl-2(S)-{3-methyl-2(S)-[(quinoline-2-carbonyl)-amino]-butyrylamino}-propionylamino)-3-methyl-butyrylamino]-propionylamino}-4-oxo-pentanoic acid methyl ester
Indication: Treatment of neonatal brain injury
Sponsor: Chiesi Farmaceutici S.P.A.
Via Palermo 26/A, 43122 Parma, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2006 Centralised Orphan - Designation EMEA/OD/055/06 (2006)5151 of 23/10/2006
22/06/2009 Other procedure
18/02/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/055/06/T/01 (2010)963 of 12/02/2010